Autoimmune Haematology
Climb Bio Inc. is active in clinical research for immune thrombocytopenia, with a focus on conditions marked by low platelet counts and immune-mediated blood disorders.
- Immune thrombocytopenia
- Platelet-related autoimmunity
- Haematologic immune disorders
The sponsor’s research in this area centres on therapeutic strategies intended to address immune-driven platelet destruction and related clinical manifestations.
Rheumatology and Systemic Autoimmunity
The sponsor also supports clinical studies in systemic lupus erythematosus, a complex autoimmune disease with multi-organ involvement and broad inflammatory effects.
- Systemic lupus erythematosus
- Autoimmune inflammation
- Multisystem immune disease
Research activity in this field reflects an interest in immune modulation for chronic systemic autoimmune conditions.
B-cell Targeted Immunology
Across its clinical portfolio, Climb Bio Inc. appears focused on therapies aimed at B-cell mediated immune pathways, relevant to both blood and systemic autoimmune disease.
- B-cell biology
- Immune pathway modulation
- Autoantibody-associated disease
This therapeutic domain connects the sponsor’s work in autoimmune disease with treatment approaches designed to alter pathogenic immune activity.
